GT Biopharma, Inc. (GTBP)
NASDAQ: GTBP · Real-Time Price · USD
2.310
+0.028 (1.23%)
Apr 25, 2025, 4:00 PM EDT - Market closed

GT Biopharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
6711299336
Upgrade
Market Cap Growth
-35.48%-35.48%-63.37%-69.01%159.67%556.05%
Upgrade
Enterprise Value
20-585758
Upgrade
Last Close Price
2.283.057.6526.5791.50216.24
Upgrade
PB Ratio
-3.46-4.081.412.464.25-1.22
Upgrade
P/TBV Ratio
--1.412.464.25-
Upgrade
Debt / Equity Ratio
--0.010.020.00-0.89
Upgrade
Quick Ratio
0.670.672.113.343.120.15
Upgrade
Current Ratio
0.720.722.123.353.140.16
Upgrade
Return on Equity (ROE)
-453.39%-453.39%-79.09%-124.15%--
Upgrade
Return on Assets (ROA)
-97.89%-97.89%-55.02%-54.33%-190.04%-139.59%
Upgrade
Return on Capital (ROIC)
-306.19%-306.19%-87.28%-78.50%-381.56%-
Upgrade
Earnings Yield
-227.60%-193.14%-71.93%-72.42%-62.35%-78.97%
Upgrade
FCF Yield
-223.14%-189.36%-83.81%-52.77%-16.77%-20.27%
Upgrade
Buyback Yield / Dilution
-40.78%-40.78%-26.87%-13.18%-542.06%-29.59%
Upgrade
Updated Feb 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q